DK523576A - Fremgangsmade til fremstilling af substituerede n-methylen-derivater af thienamycin - Google Patents

Fremgangsmade til fremstilling af substituerede n-methylen-derivater af thienamycin

Info

Publication number
DK523576A
DK523576A DK523576A DK523576A DK523576A DK 523576 A DK523576 A DK 523576A DK 523576 A DK523576 A DK 523576A DK 523576 A DK523576 A DK 523576A DK 523576 A DK523576 A DK 523576A
Authority
DK
Denmark
Prior art keywords
thienamycin
procedure
methylene derivatives
making substituted
substituted
Prior art date
Application number
DK523576A
Other languages
English (en)
Other versions
DK157401C (da
DK157401B (da
Inventor
B G Christensen
W J Leanza
K J Wildonger
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of DK523576A publication Critical patent/DK523576A/da
Publication of DK157401B publication Critical patent/DK157401B/da
Application granted granted Critical
Publication of DK157401C publication Critical patent/DK157401C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/10Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK523576A 1975-11-21 1976-11-19 Analogifremgangsmaade til fremstilling af substituerede n-methylenderivater af thienamycin DK157401C (da)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US63429675A 1975-11-21 1975-11-21
US63429675 1975-11-21
US67626176A 1976-04-12 1976-04-12
US67626176 1976-04-12
US73365476A 1976-10-18 1976-10-18
US73365476 1976-10-18

Publications (3)

Publication Number Publication Date
DK523576A true DK523576A (da) 1977-05-22
DK157401B DK157401B (da) 1990-01-02
DK157401C DK157401C (da) 1990-05-21

Family

ID=27417545

Family Applications (1)

Application Number Title Priority Date Filing Date
DK523576A DK157401C (da) 1975-11-21 1976-11-19 Analogifremgangsmaade til fremstilling af substituerede n-methylenderivater af thienamycin

Country Status (27)

Country Link
AT (1) AT358168B (da)
AU (1) AU512383B2 (da)
BG (1) BG34037A3 (da)
CA (1) CA1083577A (da)
CH (2) CH632510A5 (da)
DD (1) DD127742A5 (da)
DE (1) DE2652679A1 (da)
DK (1) DK157401C (da)
EG (1) EG12261A (da)
ES (1) ES453501A1 (da)
FI (1) FI62306C (da)
FR (1) FR2332012A1 (da)
GB (1) GB1570990A (da)
GR (1) GR62072B (da)
HK (1) HK29683A (da)
HU (1) HU180865B (da)
IE (1) IE44433B1 (da)
IL (1) IL50911A (da)
KE (1) KE3286A (da)
NL (1) NL189297C (da)
NO (1) NO153298C (da)
NZ (1) NZ182630A (da)
PH (1) PH16714A (da)
PL (1) PL110937B1 (da)
PT (1) PT65865B (da)
SE (1) SE427841B (da)
SG (1) SG10983G (da)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK153486B (da) * 1978-07-03 1988-07-18 Merck & Co Inc Analogifremgangsmaade til fremstilling af krystallinsk n-formimidoyl-thienamycin-monohydrat

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1593524A (en) * 1976-11-19 1981-07-15 Merck & Co Inc 1-carba-2-penem-3-carboxylic acids
DK170778A (da) * 1977-05-05 1979-01-15 Merck & Co Inc Fremgangsmaade til fremstilling af n-alkyl-n-iminomethyl-derivater af thienamycin
US4232030A (en) * 1977-09-15 1980-11-04 Merck & Co., Inc. Substituted N-methylene derivatives of thienamycin sulfoxide and sulfone
EP0044170A1 (en) * 1980-07-11 1982-01-20 Beecham Group Plc Beta-lactam antibiotics, their preparation and use
CA2089261A1 (en) * 1990-08-30 1992-03-01 John F.W. Keana Substituted amidines having high binding to the sigma receptor and the use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1004670A (en) * 1963-04-23 1965-09-15 Beecham Res Lab Penicillins
GB1348985A (en) * 1970-06-16 1974-03-27 Merck & Co Inc Esters of cephalosporin compounds
US3950357A (en) * 1974-11-25 1976-04-13 Merck & Co., Inc. Antibiotics

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK153486B (da) * 1978-07-03 1988-07-18 Merck & Co Inc Analogifremgangsmaade til fremstilling af krystallinsk n-formimidoyl-thienamycin-monohydrat

Also Published As

Publication number Publication date
FI62306B (fi) 1982-08-31
IL50911A (en) 1981-01-30
GR62072B (en) 1979-02-20
IE44433L (en) 1977-05-21
HU180865B (en) 1983-04-29
FR2332012B1 (da) 1978-11-17
AU1964776A (en) 1978-05-25
KE3286A (en) 1983-06-17
DE2652679A1 (de) 1977-06-02
NO153298B (no) 1985-11-11
PT65865B (en) 1978-10-12
DD127742A5 (de) 1977-10-12
NZ182630A (en) 1979-07-11
GB1570990A (en) 1980-07-09
SE7612963L (sv) 1977-05-22
DK157401C (da) 1990-05-21
SG10983G (en) 1983-12-16
AT358168B (de) 1980-08-25
PL110937B1 (en) 1980-08-30
DE2652679C2 (da) 1990-03-01
BG34037A3 (en) 1983-06-15
FI62306C (fi) 1982-12-10
NO763958L (da) 1977-05-24
PL193809A1 (pl) 1978-01-16
EG12261A (en) 1978-12-31
DK157401B (da) 1990-01-02
FI763308A (da) 1977-05-22
HK29683A (en) 1983-08-26
IE44433B1 (en) 1981-12-02
NL189297B (nl) 1992-10-01
NL189297C (nl) 1993-03-01
NO153298C (no) 1986-02-19
PH16714A (en) 1984-01-25
CA1083577A (en) 1980-08-12
CH633800A5 (en) 1982-12-31
SE427841B (sv) 1983-05-09
ATA863476A (de) 1980-01-15
IL50911A0 (en) 1977-01-31
FR2332012A1 (fr) 1977-06-17
NL7612939A (nl) 1977-05-24
AU512383B2 (en) 1980-10-09
ES453501A1 (es) 1978-03-01
CH632510A5 (en) 1982-10-15
PT65865A (en) 1976-12-01

Similar Documents

Publication Publication Date Title
DK567376A (da) Fremgangsmade til fremstilling af quinazolonderivater
DK494876A (da) Fremgangsmade til fremstilling af piperidinderivater
DK554179A (da) Fremgangsmaade til fremstilling af ergolinderivater
DK170678A (da) Fremgangsmaade til fremstilling af n-alkyl-n-acyl-derivater af thienamycin
DK462376A (da) Fremgangsmade til fremstilling af 5-halogenpyrimidinderivater
DK68976A (da) Fremgangsmade til fremstilling af enolderivater
DK545076A (da) Fremgangsmade til fremstilling af imidazolderivater
DK127876A (da) Fremgangsmade til fremstilling af nitrofurylpyrazolderivater
DK272676A (da) Fremgangsmade til fremstilling af cephalosporinforbindelser
DK523676A (da) Fremgangsmade til fremstilling af n-alkylerede derivater af thienamycin
DK149194C (da) Fremgangs-maade til fremstilling af (r)-n-phenylalaninderivater
DK528976A (da) Fremgangsmade til fremstilling af indazolderivater
DK324176A (da) Fremgangsmade til fremstilling af orthoaminobutyrophenonderivater
DK298476A (da) Fremgangsmade til fremstilling af 5-benzyl-2-oxazolidonderivater
DK523576A (da) Fremgangsmade til fremstilling af substituerede n-methylen-derivater af thienamycin
DK137275C (da) Fremgangsmaade til fremstilling af 4-oxo-hexahydropyrazinoisoquinolinderivater
DK565676A (da) Fremgangsmade til fremstilling af klavamderivater
DK356676A (da) Fremgangsmade til fremstilling af pyrazolderivater
DK551076A (da) Fremgangsmade til fremstilling af trifluormethylthio-derivater af cyproheptadin
DK343976A (da) Fremgangsmade til fremstilling af 5-androsten-17-on-derivater
DK162976A (da) Fremgangsmade til fremstilling af heterocycliske forbindelser
DK251176A (da) Fremgangsmade til fremstilling af cyklopropanolderivater
DK253676A (da) Fremgangsmade til fremstilling af cycloheptathiopenderivater
DK523276A (da) Fremgangsmade til fremstilling af n-acylderivater af thienamycin
DK18976A (da) Fremgangsmade til fremstilling af 2-aminoacetamido-alfa-phenylbenzylidenaminoalkanolderivater

Legal Events

Date Code Title Description
PUP Patent expired